News
El grupo Ictus Traslacional recoge el premio de la RAGC por su proyecto para desarrollar un nuevo tratamiento para el ictus isquémico, que afecta anualmente en Galicia a 7.000 personas
Francisco Campos, líder del grupo del IDIS, destacó la importancia de la transferencia tecnológica para que “los avances científicos no queden en el laboratorio y se conviertan en soluciones concretas que mejoren la salud y la calidad de vida de las personas”
Se presenta NEW HEALTH un proyecto europeo de cooperación transfronteriza en salud entre Galicia – Norte de Portugal liderado por la Fundación Pública Galega IDIS
Se trata de avanzar en un modelo sanitario más eficiente, conectado y centrado en el paciente de la Eurorregión Galicia–Norte de Portugal a través de la gobernanza colaborativa, la aplicación de tecnologías emergentes y la investigación en oncología y enfermedades cardiovasculares
El proyecto europeo NEW HEALTH impulsa una nueva era de la asistencia sanitaria centrada en el paciente
El proyecto NEW HEALTH, liderado desde el IDIS, se presentará el próximo 14 de abril en la Cidade da Cultura de Galicia como una iniciativa estratégica de cooperación transfronteriza en salud financiado por la Unión Europa a través del Programa de Cooperación Trasfronteriza España- Portugal – POCTEP.
Calendar
COMMON SUPPORT PLATFORMS
The platforms are research support units featured by a high strategic value, equipped by cutting edge technologies and operated by highly specialised technical staff.
CALLS
All updated information on public and private competitive calls. The most convenient and safest way to send your requests.
CAREERS
Would you like to join our team? We are always looking for people with a passion for research and propelled by insatiable curiosity to join our mission of providing a better healthcare day every day. Here you can see and apply for our current vacancies.
Research Areas
ONCOLOGY
Improvement of treatments: personalised therapy and reduction of side effects.
GENETICS AND SYSTEMS BIOLOGY
Identification of genetic biomarkers of disease susceptibility and prognosis
ENDOCRINOLOGÍA, NUTRICIÓN Y METABOLISMO
The area studies obesity from different perspectives with the participation of groups from the clinical and basic fields in a synergistic way.
NEUROSCIENCES
Search for new therapeutic targets and improvement of the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s, Parkinson’s disease, headaches and neurological diseases caused by prions.
CARDIOVASCULAR
The general objective of the Cardiovascular Area consists of the search for new therapeutic targets and the improvement of clinical-therapeutic management.
PLATFORMS AND METODOLOGY
The area aims at providing evidence for prioritising the management of public resources, evaluating risks and identifying opportunities for improving the health of the population. From here, prioritise structural investments and action programs.
Area Leader A004 - Neurosciences. Lead researcher of group C018 - Experimental Neurology of Parkinson's Disease
Area Leader A006 - Cardiovascular. Lead Researcher of group C016 - Cardiology
Area Leader A005 - Platforms and Methodology. Lead Researcher of group C015 - Research Methodology
Area Leader A001 - Oncology. Lead Researcher of the group C030 - Translational Medical Oncology
Scientific Director of the IDIS - Lead Researcher of group C012 - Metabolic Disorders
Area leader A002 - Genetics and Systems Biology. Lead Researcher of the group C002 - Genetics
Leader Area A003 - Endocrinology, nutrition and metabolism. Leader of group C006 - Molecular endocrinology
Area Leader A007 - Infectology, Inflammation and Vaccines. Lead researcher of the group C020 - Genetics, Vaccines, Infections and Paedriatics (GENVIP)
